Skip to content

Simvastatin effect on orthodontic relapse

Evaluation the effects of subgingival injection of Simvastatin on prevention of the tooth relapse after orthodontic movements

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013041813054N1
Enrollment
24
Registered
2013-11-04
Start date
2013-04-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

orthodontic relapse. Fitting and adjustment of orthodontic device

Interventions

Intervention 1: For control group: normal saline injection (1 .2 mg) in the sixth front teeth depth pocket, two weeks after bleaching. Intervention 2: For intervention group: simvastatin injection in
Treatment - Drugs
For control group: normal saline injection (1 .2 mg) in the sixth front teeth depth pocket, two weeks after bleaching
For intervention group: simvastatin injection in the sixth front teeth depth pocket with 1.2 mg for each inter proximal section, two weeks after bleaching

Sponsors

Vice chancellor for research, Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Female patients with 20 to 45 years old, with 4 to 6 mm space between front teeth of upper or lower gingival, controlled chronic periodontitis with Clinical Attachment Loss of 4 to 6 mm and without known allergy to simvastatin group medicines. Big tongue was not the cause of space. Exclusion criteria: Patients under systemic therapy with simvastatin group medicines, pregnant or breath feeding patients, sever periodontitis patients, smoker or alcoholic patients, patients with diabetes or immunosuppressive diseases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Gingival index. Timepoint: Before the study and eight weeks after injection in control and intervention group. Method of measurement: According to bleeding index.;Clinical Attachment Loss. Timepoint: Before the study and eight weeks after injection in control and intervention group. Method of measurement: By Probe.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Parasto Namdar

Mashad University of Medical Sciences

NamdarP881@mums.ac.ir+98 51 1883 0787

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026